Aspen Aerogels, Inc. (ASPN) Receives Average Rating of “Hold” from Brokerages
Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have been given a consensus rating of “Hold” by the seven ratings firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $6.38.
A number of brokerages recently weighed in on ASPN. Zacks Investment Research raised shares of Aspen Aerogels from a “hold” rating to a “buy” rating and set a $4.75 price objective for the company in a research report on Tuesday, September 12th. ValuEngine downgraded shares of Aspen Aerogels from a “sell” rating to a “strong sell” rating in a research report on Friday, July 28th. Finally, Citigroup Inc. boosted their price objective on shares of Aspen Aerogels from $4.50 to $4.75 and gave the company a “neutral” rating in a research report on Tuesday, May 30th.
Shares of Aspen Aerogels (NYSE:ASPN) traded down 3.56% during trading on Friday, hitting $4.06. The company’s stock had a trading volume of 82,637 shares. The company’s market cap is $83.56 million. The firm’s 50 day moving average price is $4.36 and its 200-day moving average price is $4.27. Aspen Aerogels has a 52 week low of $3.61 and a 52 week high of $6.71.
Aspen Aerogels (NYSE:ASPN) last released its earnings results on Thursday, August 3rd. The construction company reported ($0.23) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.24) by $0.01. The company had revenue of $25.10 million during the quarter, compared to the consensus estimate of $24.79 million. Aspen Aerogels had a negative net margin of 22.22% and a negative return on equity of 20.95%. The company’s revenue was down 9.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.02) EPS. On average, analysts predict that Aspen Aerogels will post ($0.86) earnings per share for the current year.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Spark Investment Management LLC grew its position in Aspen Aerogels by 186.0% in the 1st quarter. Spark Investment Management LLC now owns 30,600 shares of the construction company’s stock worth $126,000 after purchasing an additional 19,900 shares during the last quarter. Mesirow Financial Investment Management Inc. bought a new position in Aspen Aerogels in the 2nd quarter worth about $330,000. Renaissance Technologies LLC grew its position in Aspen Aerogels by 12.5% in the 1st quarter. Renaissance Technologies LLC now owns 262,500 shares of the construction company’s stock worth $1,089,000 after purchasing an additional 29,200 shares during the last quarter. Royce & Associates LP grew its position in Aspen Aerogels by 39.6% in the 1st quarter. Royce & Associates LP now owns 413,924 shares of the construction company’s stock worth $1,718,000 after purchasing an additional 117,397 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in Aspen Aerogels by 0.5% in the 2nd quarter. Vanguard Group Inc. now owns 582,689 shares of the construction company’s stock worth $2,592,000 after purchasing an additional 3,158 shares during the last quarter. Hedge funds and other institutional investors own 74.41% of the company’s stock.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
Receive News & Ratings for Aspen Aerogels Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels Inc. and related companies with MarketBeat.com's FREE daily email newsletter.